Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity.
Tabatabaei Dakhili SA, Yang K, Al Nebaihi H, Greenwell AA, Wuest M, Woodfield J, Farraj RA, Saed CT, Chan JSF, Bhat RK, Mangra-Bala IA, Shafaati T, Gopal K, Eaton F, Ferrari SR, Wagg CS, Capozzi ME, Campbell JE, Overduin M, Velazquez-Martinez CA, Glover JNM, Wuest F, Brocks DR, Ussher JR.
Tabatabaei Dakhili SA, et al. Among authors: wagg cs.
iScience. 2025 Apr 3;28(5):112336. doi: 10.1016/j.isci.2025.112336. eCollection 2025 May 16.
iScience. 2025.
PMID: 40454095
Free PMC article.